Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Zeptomole per milliliter detection and quantification of edema factor in plasma by LC-MS/MS yields insights into toxemia and the progression of inhalation anthrax.

Lins RC, Boyer AE, Kuklenyik Z, Woolfitt AR, Goldstein J, Hoffmaster AR, Gallegos-Candela M, Leysath CE, Chen Z, Brumlow JO, Quinn CP, Bagarozzi DA Jr, Leppla SH, Barr JR.

Anal Bioanal Chem. 2019 May;411(12):2493-2509. doi: 10.1007/s00216-019-01730-4. Epub 2019 Mar 26.

PMID:
30911800
2.

Development and validation of a robust multiplex serological assay to quantify antibodies specific to pertussis antigens.

Rajam G, Carlone G, Kim E, Choi J, Paulos S, Park S, Jeyachandran A, Gorantla Y, Wong E, Sabnis A, Browning P, Desai R, Quinn CP, Schiffer J.

Biologicals. 2019 Jan;57:9-20. doi: 10.1016/j.biologicals.2018.11.001. Epub 2018 Nov 18.

PMID:
30458978
3.

Galactosylation of the Secondary Cell Wall Polysaccharide of Bacillus anthracis and Its Contribution to Anthrax Pathogenesis.

Chateau A, Lunderberg JM, Oh SY, Abshire T, Friedlander A, Quinn CP, Missiakas DM, Schneewind O.

J Bacteriol. 2018 Feb 7;200(5). pii: e00562-17. doi: 10.1128/JB.00562-17. Print 2018 Mar 1.

4.

Validated MALDI-TOF-MS method for anthrax lethal factor provides early diagnosis and evaluation of therapeutics.

Gallegos-Candela M, Boyer AE, Woolfitt AR, Brumlow J, Lins RC, Quinn CP, Hoffmaster AR, Meister G, Barr JR.

Anal Biochem. 2018 Feb 15;543:97-107. doi: 10.1016/j.ab.2017.12.007. Epub 2017 Dec 7.

5.

Structural and immunochemical relatedness suggests a conserved pathogenicity motif for secondary cell wall polysaccharides in Bacillus anthracis and infection-associated Bacillus cereus.

Kamal N, Ganguly J, Saile E, Klee SR, Hoffmaster A, Carlson RW, Forsberg LS, Kannenberg EL, Quinn CP.

PLoS One. 2017 Aug 23;12(8):e0183115. doi: 10.1371/journal.pone.0183115. eCollection 2017.

6.

Analysis of Anthrax Immune Globulin Intravenous with Antimicrobial Treatment in Injection Drug Users, Scotland, 2009-2010.

Cui X, Nolen LD, Sun J, Booth M, Donaldson L, Quinn CP, Boyer AE, Hendricks K, Shadomy S, Bothma P, Judd O, McConnell P, Bower WA, Eichacker PQ.

Emerg Infect Dis. 2017 Jan;23(1):56-65. doi: 10.3201/eid2301.160608.

7.

Epidemiology of Pertussis Among Young Pakistani Infants: A Community-Based Prospective Surveillance Study.

Omer SB, Kazi AM, Bednarczyk RA, Allen KE, Quinn CP, Aziz F, Sial K, Phadke VK, Tondella ML, Williams MM, Orenstein WA, Ali SA.

Clin Infect Dis. 2016 Dec 1;63(suppl 4):S148-S153.

8.

Cross-species prediction of human survival probabilities for accelerated anthrax vaccine absorbed (AVA) regimens and the potential for vaccine and antibiotic dose sparing.

Stark GV, Sivko GS, VanRaden M, Schiffer J, Taylor KL, Hewitt JA, Quinn CP, Nuzum EO.

Vaccine. 2016 Dec 12;34(51):6512-6517. doi: 10.1016/j.vaccine.2016.06.041. Epub 2016 Aug 22.

9.

Anthrax Toxin-Expressing Bacillus cereus Isolated from an Anthrax-Like Eschar.

Marston CK, Ibrahim H, Lee P, Churchwell G, Gumke M, Stanek D, Gee JE, Boyer AE, Gallegos-Candela M, Barr JR, Li H, Boulay D, Cronin L, Quinn CP, Hoffmaster AR.

PLoS One. 2016 Jun 3;11(6):e0156987. doi: 10.1371/journal.pone.0156987. eCollection 2016.

10.

Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Adsorbed vaccination and Bacillus anthracis spore challenge.

Sivko GS, Stark GV, Tordoff KP, Taylor KL, Glaze E, VanRaden M, Schiffer JM, Hewitt JA, Quinn CP, Nuzum EO.

Vaccine. 2016 Dec 12;34(51):6518-6528. doi: 10.1016/j.vaccine.2016.04.048. Epub 2016 May 4.

11.

Recent developments in the understanding and use of anthrax vaccine adsorbed: achieving more with less.

Schiffer JM, McNeil MM, Quinn CP.

Expert Rev Vaccines. 2016 Sep;15(9):1151-62. doi: 10.1586/14760584.2016.1162104. Epub 2016 Mar 25. Review.

PMID:
26942655
12.

Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans.

Quinn CP, Sabourin CL, Schiffer JM, Niemuth NA, Semenova VA, Li H, Rudge TL, Brys AM, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Parker SD, Babcock J, Keitel W, Poland GA, Keyserling HL, El Sahly H, Jacobson RM, Marano N, Plikaytis BD, Wright JG.

Clin Vaccine Immunol. 2016 Apr 4;23(4):326-38. doi: 10.1128/CVI.00696-15. Print 2016 Apr.

13.

Antitoxin Treatment of Inhalation Anthrax: A Systematic Review.

Huang E, Pillai SK, Bower WA, Hendricks KA, Guarnizo JT, Hoyle JD, Gorman SE, Boyer AE, Quinn CP, Meaney-Delman D.

Health Secur. 2015 Nov-Dec;13(6):365-77. doi: 10.1089/hs.2015.0032. Review.

14.

Bridging non-human primate correlates of protection to reassess the Anthrax Vaccine Adsorbed booster schedule in humans.

Schiffer JM, Chen L, Dalton S, Niemuth NA, Sabourin CL, Quinn CP.

Vaccine. 2015 Jul 17;33(31):3709-16. doi: 10.1016/j.vaccine.2015.05.091. Epub 2015 Jun 10.

15.

Evaluation of anthrax vaccine safety in 18 to 20 year olds: A first step towards age de-escalation studies in adolescents.

King JC Jr, Gao Y, Quinn CP, Dreier TM, Vianney C, Espeland EM.

Vaccine. 2015 May 15;33(21):2470-6. doi: 10.1016/j.vaccine.2015.03.071. Epub 2015 Apr 5.

PMID:
25850022
16.

Anthrax vaccine recipients lack antibody against the loop neutralizing determinant: A protective neutralizing epitope from Bacillus anthracis protective antigen.

Oscherwitz J, Quinn CP, Cease KB.

Vaccine. 2015 May 11;33(20):2342-6. doi: 10.1016/j.vaccine.2015.03.037. Epub 2015 Mar 26.

17.

High-sensitivity MALDI-TOF MS quantification of anthrax lethal toxin for diagnostics and evaluation of medical countermeasures.

Boyer AE, Gallegos-Candela M, Quinn CP, Woolfitt AR, Brumlow JO, Isbell K, Hoffmaster AR, Lins RC, Barr JR.

Anal Bioanal Chem. 2015 Apr;407(10):2847-58. doi: 10.1007/s00216-015-8509-5. Epub 2015 Feb 12.

18.

Comprehensive analysis and selection of anthrax vaccine adsorbed immune correlates of protection in rhesus macaques.

Chen L, Schiffer JM, Dalton S, Sabourin CL, Niemuth NA, Plikaytis BD, Quinn CP.

Clin Vaccine Immunol. 2014 Nov;21(11):1512-20. doi: 10.1128/CVI.00469-14. Epub 2014 Sep 3.

19.

Detection of anthrax protective antigen (PA) using europium labeled anti-PA monoclonal antibody and time-resolved fluorescence.

Stoddard RA, Quinn CP, Schiffer JM, Boyer AE, Goldstein J, Bagarozzi DA, Soroka SD, Dauphin LA, Hoffmaster AR.

J Immunol Methods. 2014 Jun;408:78-88. doi: 10.1016/j.jim.2014.05.008. Epub 2014 May 22.

20.

Pertussis pathogenesis--what we know and what we don't know.

Hewlett EL, Burns DL, Cotter PA, Harvill ET, Merkel TJ, Quinn CP, Stibitz ES.

J Infect Dis. 2014 Apr 1;209(7):982-5. doi: 10.1093/infdis/jit639. Review.

21.

Lethal factor and anti-protective antigen IgG levels associated with inhalation anthrax, Minnesota, USA.

Sprenkle MD, Griffith J, Marinelli W, Boyer AE, Quinn CP, Pesik NT, Hoffmaster A, Keenan J, Juni BA, Blaney DD.

Emerg Infect Dis. 2014 Feb;20(2):310-4. doi: 10.3201/eid2002.130245.

22.

Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial.

Wright JG, Plikaytis BD, Rose CE, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Semenova VA, Li H, Schiffer J, Dababneh H, Martin SK, Martin SW, Marano N, Messonnier NE, Quinn CP.

Vaccine. 2014 Feb 12;32(8):1019-28. doi: 10.1016/j.vaccine.2013.10.039. Epub 2013 Dec 25.

PMID:
24373307
23.

Human leukocyte antigens and cellular immune responses to anthrax vaccine adsorbed.

Ovsyannikova IG, Pankratz VS, Vierkant RA, Pajewski NM, Quinn CP, Kaslow RA, Jacobson RM, Poland GA.

Infect Immun. 2013 Jul;81(7):2584-91. doi: 10.1128/IAI.00269-13. Epub 2013 May 6.

24.

The secondary cell wall polysaccharide of Bacillus anthracis provides the specific binding ligand for the C-terminal cell wall-binding domain of two phage endolysins, PlyL and PlyG.

Ganguly J, Low LY, Kamal N, Saile E, Forsberg LS, Gutierrez-Sanchez G, Hoffmaster AR, Liddington R, Quinn CP, Carlson RW, Kannenberg EL.

Glycobiology. 2013 Jul;23(7):820-32. doi: 10.1093/glycob/cwt019. Epub 2013 Mar 14.

25.

Quantitative assessment of anthrax vaccine immunogenicity using the dried blood spot matrix.

Schiffer JM, Maniatis P, Garza I, Steward-Clark E, Korman LT, Pittman PR, Mei JV, Quinn CP.

Biologicals. 2013 Mar;41(2):98-103. doi: 10.1016/j.biologicals.2012.11.003. Epub 2012 Dec 21.

PMID:
23266055
26.

Anthrax vaccine-induced antibodies provide cross-species prediction of survival to aerosol challenge.

Fay MP, Follmann DA, Lynn F, Schiffer JM, Stark GV, Kohberger R, Quinn CP, Nuzum EO.

Sci Transl Med. 2012 Sep 12;4(151):151ra126. doi: 10.1126/scitranslmed.3004073.

27.

Endolysins of Bacillus anthracis bacteriophages recognize unique carbohydrate epitopes of vegetative cell wall polysaccharides with high affinity and selectivity.

Mo KF, Li X, Li H, Low LY, Quinn CP, Boons GJ.

J Am Chem Soc. 2012 Sep 19;134(37):15556-62. Epub 2012 Sep 11. Erratum in: J Am Chem Soc. 2012 Dec 5;134(48):19948.

28.

A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.

Quinn CP, Sabourin CL, Niemuth NA, Li H, Semenova VA, Rudge TL, Mayfield HJ, Schiffer J, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Brys AM, Hunt RE, Levesque D, Estep JE, Barnewall RE, Robinson DM, Plikaytis BD, Marano N; AVRP Laboratory Working Group.

Clin Vaccine Immunol. 2012 Nov;19(11):1730-45. doi: 10.1128/CVI.00324-12. Epub 2012 Aug 29.

29.

Zoonotic infections among employees from Great Smoky Mountains and Rocky Mountain National Parks, 2008-2009.

Adjemian J, Weber IB, McQuiston J, Griffith KS, Mead PS, Nicholson W, Roche A, Schriefer M, Fischer M, Kosoy O, Laven JJ, Stoddard RA, Hoffmaster AR, Smith T, Bui D, Wilkins PP, Jones JL, Gupton PN, Quinn CP, Messonnier N, Higgins C, Wong D.

Vector Borne Zoonotic Dis. 2012 Nov;12(11):922-31. doi: 10.1089/vbz.2011.0917. Epub 2012 Jul 26.

30.

A genome-wide association study of host genetic determinants of the antibody response to Anthrax Vaccine Adsorbed.

Pajewski NM, Shrestha S, Quinn CP, Parker SD, Wiener H, Aissani B, McKinney BA, Poland GA, Edberg JC, Kimberly RP, Tang J, Kaslow RA.

Vaccine. 2012 Jul 6;30(32):4778-84. doi: 10.1016/j.vaccine.2012.05.032. Epub 2012 May 31.

31.
32.

Analysis of defined combinations of monoclonal antibodies in anthrax toxin neutralization assays and their synergistic action.

Ngundi MM, Meade BD, Little SF, Quinn CP, Corbett CR, Brady RA, Burns DL.

Clin Vaccine Immunol. 2012 May;19(5):731-9. doi: 10.1128/CVI.05714-11. Epub 2012 Mar 21.

33.

Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-PA IgG.

Semenova VA, Schiffer J, Steward-Clark E, Soroka S, Schmidt DS, Brawner MM, Lyde F, Thompson R, Brown N, Foster L, Fox S, Patel N, Freeman AE, Quinn CP.

J Immunol Methods. 2012 Feb 28;376(1-2):97-107. doi: 10.1016/j.jim.2011.12.002. Epub 2011 Dec 17.

PMID:
22197974
34.

Lethal factor toxemia and anti-protective antigen antibody activity in naturally acquired cutaneous anthrax.

Boyer AE, Quinn CP, Beesley CA, Gallegos-Candela M, Marston CK, Cronin LX, Lins RC, Stoddard RA, Li H, Schiffer J, Hossain MJ, Chakraborty A, Rahman M, Luby SP, Shieh WJ, Zaki S, Barr JR, Hoffmaster AR.

J Infect Dis. 2011 Nov;204(9):1321-7. doi: 10.1093/infdis/jir543. Epub 2011 Sep 9.

35.

Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations.

Veguilla V, Hancock K, Schiffer J, Gargiullo P, Lu X, Aranio D, Branch A, Dong L, Holiday C, Liu F, Steward-Clark E, Sun H, Tsang B, Wang D, Whaley M, Bai Y, Cronin L, Browning P, Dababneh H, Noland H, Thomas L, Foster L, Quinn CP, Soroka SD, Katz JM.

J Clin Microbiol. 2011 Jun;49(6):2210-5. doi: 10.1128/JCM.00229-11. Epub 2011 Apr 6.

36.

Secondary cell wall polysaccharides from Bacillus cereus strains G9241, 03BB87 and 03BB102 causing fatal pneumonia share similar glycosyl structures with the polysaccharides from Bacillus anthracis.

Forsberg LS, Choudhury B, Leoff C, Marston CK, Hoffmaster AR, Saile E, Quinn CP, Kannenberg EL, Carlson RW.

Glycobiology. 2011 Jul;21(7):934-48. doi: 10.1093/glycob/cwr026. Epub 2011 Mar 18.

37.

Quantitative mass spectrometry for bacterial protein toxins--a sensitive, specific, high-throughput tool for detection and diagnosis.

Boyer AE, Gallegos-Candela M, Lins RC, Kuklenyik Z, Woolfitt A, Moura H, Kalb S, Quinn CP, Barr JR.

Molecules. 2011 Mar 14;16(3):2391-413. doi: 10.3390/molecules16032391. Review.

38.

Antibody responses to a spore carbohydrate antigen as a marker of nonfatal inhalation anthrax in rhesus macaques.

Saile E, Boons GJ, Buskas T, Carlson RW, Kannenberg EL, Barr JR, Boyer AE, Gallegos-Candela M, Quinn CP.

Clin Vaccine Immunol. 2011 May;18(5):743-8. doi: 10.1128/CVI.00475-10. Epub 2011 Mar 9.

39.

Comparison of MALDI-TOF-MS and HPLC-ESI-MS/MS for endopeptidase activity-based quantification of Anthrax lethal factor in serum.

Kuklenyik Z, Boyer AE, Lins R, Quinn CP, Gallegos-Candela M, Woolfitt A, Pirkle JL, Barr JR.

Anal Chem. 2011 Mar 1;83(5):1760-5. doi: 10.1021/ac1030144. Epub 2011 Feb 8.

PMID:
21302970
40.

Anthrax: modern exposure science combats a deadly, ancient disease.

Barr JR, Boyer AE, Quinn CP.

J Expo Sci Environ Epidemiol. 2010 Nov;20(7):573-4. doi: 10.1038/jes.2010.49. No abstract available.

PMID:
20959831
41.

A two-stage, multilevel quality control system for serological assays in anthrax vaccine clinical trials.

Soroka SD, Schiffer JM, Semenova VA, Li H, Foster L, Quinn CP.

Biologicals. 2010 Nov;38(6):675-83. doi: 10.1016/j.biologicals.2010.09.001. Epub 2010 Sep 28.

PMID:
20875951
42.

Vaccination of rhesus macaques with the anthrax vaccine adsorbed vaccine produces a serum antibody response that effectively neutralizes receptor-bound protective antigen in vitro.

Clement KH, Rudge TL Jr, Mayfield HJ, Carlton LA, Hester A, Niemuth NA, Sabourin CL, Brys AM, Quinn CP.

Clin Vaccine Immunol. 2010 Nov;17(11):1753-62. doi: 10.1128/CVI.00174-10. Epub 2010 Aug 25.

43.

Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.

Wright JG, Quinn CP, Shadomy S, Messonnier N; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 Jul 23;59(RR-6):1-30.

44.

Kinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaques.

Boyer AE, Quinn CP, Hoffmaster AR, Kozel TR, Saile E, Marston CK, Percival A, Plikaytis BD, Woolfitt AR, Gallegos M, Sabourin P, McWilliams LG, Pirkle JL, Barr JR.

Infect Immun. 2009 Aug;77(8):3432-41. doi: 10.1128/IAI.00346-09. Epub 2009 Jun 8.

45.

Bacillus anthracis edema toxin impairs neutrophil actin-based motility.

Szarowicz SE, During RL, Li W, Quinn CP, Tang WJ, Southwick FS.

Infect Immun. 2009 Jun;77(6):2455-64. doi: 10.1128/IAI.00839-08. Epub 2009 Apr 6.

46.

Secondary cell wall polysaccharides of Bacillus anthracis are antigens that contain specific epitopes which cross-react with three pathogenic Bacillus cereus strains that caused severe disease, and other epitopes common to all the Bacillus cereus strains tested.

Leoff C, Saile E, Rauvolfova J, Quinn CP, Hoffmaster AR, Zhong W, Mehta AS, Boons GJ, Carlson RW, Kannenberg EL.

Glycobiology. 2009 Jun;19(6):665-73. doi: 10.1093/glycob/cwp036. Epub 2009 Mar 6.

47.

International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007.

Tondella ML, Carlone GM, Messonnier N, Quinn CP, Meade BD, Burns DL, Cherry JD, Guiso N, Hewlett EL, Edwards KM, Xing D, Giammanco A, Wirsing von K├Ânig CH, Han L, Hueston L, Robbins JB, Powell M, Mink CM, Poolman JT, Hildreth SW, Lynn F, Morris A.

Vaccine. 2009 Feb 5;27(6):803-14. doi: 10.1016/j.vaccine.2008.11.072. Epub 2008 Dec 9.

PMID:
19071179
48.

Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial.

Marano N, Plikaytis BD, Martin SW, Rose C, Semenova VA, Martin SK, Freeman AE, Li H, Mulligan MJ, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Soroka SD, Fox SP, Stamper JL, McNeil MM, Perkins BA, Messonnier N, Quinn CP; Anthrax Vaccine Research Program Working Group.

JAMA. 2008 Oct 1;300(13):1532-43. doi: 10.1001/jama.300.13.1532. Erratum in: JAMA. 2008 Nov 19;300(19):2252.

PMID:
18827210
49.
50.

Chemical synthesis and immunological properties of oligosaccharides derived from the vegetative cell wall of Bacillus anthracis.

Vasan M, Rauvolfova J, Wolfert MA, Leoff C, Kannenberg EL, Quinn CP, Carlson RW, Boons GJ.

Chembiochem. 2008 Jul 21;9(11):1716-20. doi: 10.1002/cbic.200800210. No abstract available.

Supplemental Content

Loading ...
Support Center